Dublin, May 25, 2021 (GLOBE NEWSWIRE) -- The "Flow Cytometry Market Based on Technology, Product and Service, Application, End-User, and Geography - Global Forecast up to 2026" report has been added to ResearchAndMarkets.com's offering.
The Flow Cytometry Market is projected to grow at the rate of 8.7% CAGR by 2026. Flow cytometry is a biophysical, laser-based analytical technology that calculates and analyzes various physical features of cells or particles present in a fluid when passed through a laser beam. Flow cytometry has several benefits over conventional analytical techniques such as ELISA, including its capability to provide accurate results within less time at about similar prices.
The key factors propelling the flow cytometry market include the emergence and commercial application of advanced technologies in flow cytometry and the increase in the adoption of flow cytometry in stem cell research and clinical research. Apart from that, the inadequate purchasing power of end-users in emerging countries and high product costs are the factors to impede the growth of the flow cytometry market.
Flow Cytometry Market based on Technology
Cell-based Flow Cytometry
Bead-based Flow Cytometry
Flow Cytometry Market based on Product and Service
Reagents & Consumables
Flow Cytometry Market based on Application
Flow Cytometry Market based on End-User
Academic & Research Institutes
Hospitals & Clinical Testing Laboratories
Pharmaceutical & Biotechnology Companies
Flow Cytometry Market based on Geography
Rest of the World
The cell-based flow cytometry technology leads the overall market to maintain its dominance over the forecast period. Growing demand for early diagnosis and increasing consciousness regarding the advantages of cell-based flow cytometry are the factors contributing to its dominance. Moreover, technology has enormous applications in many research domains. The cell-based flow cytometry technology is mainly used in drug discovery for the physiological significance of the results.
In the market for products & services, the reagents & consumables segment has the most significant market share. This is due to the high penetration along with the benefits such as precise outcomes and user-friendly. Moreover, the introduction of new technologies and their detection capability also boost the demand for the products and services.
As per the application segmentation, the research segment has held a significant share in the market. This segment's major share is attributed to the rising number of research and development activities concerning cancer and other diseases. This technology is mostly used in pharmaceutical research and also has application in various researches.
The commercial organization segment has acquired the maximum share in the market due to the vast application of this technology in various verticals. The emergence of several probes and reagents for particular applications in diagnostics and drug discovery is predicted to generate numerous growth opportunities for the segment by serving the users in research and small peripheral laboratories.
North America has occupied the highest share in the flow cytometry market. This is due to the early adoption of advanced technology, high investments in research and developments, and widespread flow cytometry application in diagnostic activities.
High precision of measurement performance by using flow cytometers and the related valuable outcomes accelerates the global demand for flow cytometers among clinicians, drug developers, and food safety technicians. Moreover, higher sensitivity, easy-to-use analysis, and quick outcomes associated with flow cytometry will also likely drive the flow cytometers' global market growth soon.
Some of the major players of the flow cytometry market are Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, Merck KGaA, Sony Biotechnology and Inc. and BioMerieux S.A.
Hence, flow cytometry is deemed to be a perfect tool for research and potential clinical use. With such exclusive usage of flow cytometry for efficient diagnosis and early discovery of diseases, stem cell research is propelling the flow cytometry market's growth.
This study defines, elucidates, and analyzes the overall flow cytometry market competition and the key market competitors' SWOT analysis.
This study also describes and predicts the market by covering all the segmentations, including geographical analysis.
This study will help analyze the worldwide market trends, opportunities for the market players, the challenges faced by the market players, and the market's geographical penetration across the world.
Key Topics Covered:
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.4. DRO - Impact Analysis
5. Technology: Market Size & Analysis
5.2. Cell-based Flow Cytometry
5.3. Bead-based Flow Cytometry
6. PRODUCT & SERVICE: Market Size & Analysis
6.2. Reagents & Consumables
7. Application: Market Size & Analysis
7.2. Research Applications
7.3. Clinical Applications
7.4. Industrial Applications
8. END-USER: Market Size & Analysis
8.2. Academic & Research Institutes
8.3. Hospitals & Clinical Testing Laboratories
8.4. Pharmaceutical & Biotechnology Companies
8.5. Commercial organizations
9. Geography: Market Size & Analysis
9.2. North America
9.4. Asia Pacific
9.5. Rest of the World
10. Competitive Landscape
10.1. Competitor Comparison Analysis
10.2. Market Developments
10.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
10.2.2. Product Launches and execution
11. Vendor Profiles
11.1. Beckman Coulter, Inc.
11.1.2. Financial Overview
11.1.3. Product END-USERs
11.1.5. Business Strategy
11.2. Bio-Rad Laboratories, Inc.
11.2.2. Financial Overview
11.2.3. Product END-USERs
11.2.5. Business Strategy
11.3. Becton, Dickinson and Company
11.3.2. Financial Overview
11.3.3. Product END-USERs
11.3.5. Business Strategy
11.4. Thermo Fisher Scientific, Inc.
11.4.2. Financial Overview
11.4.3. Product END-USERs
11.4.5. Business Strategy
11.5. Agilent Technologies, Inc.
11.5.2. Financial Overview
11.5.3. Product END-USERs
11.5.5. Business Strategy
11.6. Sysmex Partec GmbH
11.6.2. Financial Overview
11.6.3. Product END-USERs
11.6.5. Business Strategy
11.7. Luminex Corporation
11.7.2. Financial Overview
11.7.3. Product END-USERs
11.7.5. Business Strategy
11.8. Miltenyi Biotec GmbH
11.8.2. Financial Overview
11.8.3. Product END-USERs
11.8.5. Business Strategy
11.9. Merck KGaA
11.9.2. Financial Overview
11.9.3. Product END-USERs
11.9.5. Business Strategy
11.10. Sony Biotechnology and Inc.
11.10.2. Financial Overview
11.10.3. Product END-USERs
11.10.5. Business Strategy
12. Companies to Watch
12.1. BioMerieux S.A.
12.1.2. Products & Services
12.1.3. Business Strategy
13. Analyst Opinion
For more information about this report visit https://www.researchandmarkets.com/r/bdrsrp
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900